International Clinical Trial: Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07437950) titled 'Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: National Cancer Institute (NCI)

Condition: Acute Myeloid Leukemia

Intervention: Procedure: Biospecimen Collection Procedure: Bone Marrow Aspiration Drug: Decitabine and Cedazuridine

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 14, 2026

Target...